Ferdinand Apolonio Mortel

Dr. Ferdinand Apolonio Mortel

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2026 in Virulence
Verified
Journal Article
Open access
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
COChristian Joseph Ong
Christian Joseph Ong
Ferdinand Apolonio MortelFerdinand Apolonio Mortel
Ferdinand Apolonio Mortel
GBGrace D. Bacalzo
Grace D. Bacalzo
JNJose Jurel M. Nuevo
Jose Jurel M. Nuevo
Acinetobacter baumannii, once regarded as a low-virulence organism, has emerged as a major global pathogen due to the rapid dissemination of multidrug-resistant (MDR), extensively drug-resistant (X...

31 December 2025 in European Journal of Microbiology and Immunology
Verified
Journal Article
Open access
KCKevin Smith Puno Cabuhat
Kevin Smith Puno Cabuhat
TTTroy Vincent C. Tan
Troy Vincent C. Tan
COChristian Joseph Ong
Christian Joseph Ong
Ferdinand Apolonio MortelFerdinand Apolonio Mortel
Ferdinand Apolonio Mortel
GBGrace D. Bacalzo
Grace D. Bacalzo
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
Antimicrobial resistance (AMR), particularly in methicillin-resistant Staphylococcus aureus (MRSA), continues to threaten global health due to its multidrug resistance and strong biofilm-forming ability. Antimicrobial peptides (AMPs) have emerged as promising agents against MRSA biofilms because of their diverse origins, structural versatility, and unique modes of action. Natural AMPs derived from animals, plants, fungi, protists, archaea, and bacteria primarily act by disrupting bacterial membranes, interfering with quorum sensing, and downregulating biofilm-related genes such as sarA , icaA , and icaD . Synthetic AMPs, designed through computational modeling and machine learning, demonstrate enhanced stability, reduced toxicity, and improved target specificity. Synergistic AMP–antibiotic combinations, including nisin, indolicidin, and α-MSH analogs with β-lactams, significantly improve antibiofilm efficacy and bacterial clearance. Despite these advances, challenges persist due to peptide instability, enzymatic degradation, cytotoxicity, and limited in vivo validation. Recent developments in nanoparticle, hydrogel, coatings, and nanofiber delivery systems have improved AMP bioavailability and controlled release within biofilms. Continued integration of peptide engineering, nanotechnology, and bioinformatics-driven design offers promising solutions for clinical translation. Overall, AMPs represent a frontier in combating MRSA biofilms and antibiotic resistance, with future research focusing on stability enhancement, resistance prevention, and optimized therapeutic delivery.

10 September 2026 in Biology
Verified
Journal Article
Open access
PDF file
COChristian Joseph Ong
Christian Joseph Ong
Johnalie Nagal CabalbagJohnalie Nagal Cabalbag
Johnalie Nagal Cabalbag
JCJowi Tsidkenu Pili Cruz
Jowi Tsidkenu Pili Cruz
Teodora ValderamaTeodora Valderama
Teodora Valderama
CRCelia Roble Roslin
Celia Roble Roslin
JFJamil Allen Gamboa Fortaleza
Jamil Allen Gamboa Fortaleza
Southeast Asia faces a substantial burden of antimicrobial resistance (AMR), creating increasing interest in bacteriophage-based antimicrobial strategies. However, the regional development, contributors, collaboration patterns, and evolving research priorities of this field remain insufficiently characterized. This study conducted a bibliometric analysis of Scopus-indexed publications on bacteriophage-based antimicrobial research affiliated with Southeast Asian countries from 1981 to 2025. Bibliometrix/Biblioshiny and VOSviewer were used to evaluate scientific production, citation patterns, leading contributors, collaboration networks, and conceptual and thematic development. A total of 862 publications were analyzed, with scientific output accelerating markedly after 2019 and reaching its highest level in 2025. Thailand emerged as the dominant regional contributor, with Vongkamjan (n = 21) and Surachat (n = 20) as the two most prolific authors. Mahidol University (n = 182), Prince of Songkla University (n = 142), and Universiti Putra Malaysia (n = 139) were the leading institutions, demonstrating a concentration of research capacity in Thailand and Malaysia. Scientific Reports was the most productive journal (30 publications), whereas Frontiers in Microbiology recorded the highest citation count among the leading sources (963 citations). Collaboration mapping revealed increasingly interconnected regional and international research networks. Thematic analyses demonstrated a transition from foundational and pathogen-specific investigations toward AMR, bacteriophage therapy, biofilm control, aquaculture, genomic and comparative genomic analysis, wastewater and public-health applications, and One Health-oriented research. Emerging topics included endolysins, quorum sensing, CRISPR-associated approaches, metagenomics, and genome-informed phage characterization. These findings demonstrate the rapid expansion and thematic diversification of bacteriophage-based antimicrobial research in Southeast Asia while highlighting persistent geographic concentration and the need for stronger regional infrastructure, collaboration, and translational capacity.